
Renjing Bio
仁景生物
Renjing Bio
Biotech/Healthcare
Renjing Bio is a drug developer focused on mRNA-based therapeutics, providing clinical research and drug R&D services. Located in Suzhou BioBay, the company is dedicated to researching and developing innovative medicines based on mRNA technology.
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.